LCM
VIR icon

Landscape Capital Management’s Vir Biotechnology VIR Stock Holding History

Landscape Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,174
Closed -$91.2K – 927
2026
Q1 		$91.2K Buy
+10,174
New +$81.1K 0.01% 686
2024
Q1 		– Sell
-48,606
Closed -$489K – 996
2023
Q4 		$489K Buy
+48,606
New +$444K 0.04% 416

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Landscape Capital Management's VIR Position: Q2 2026 in Review

Landscape Capital Management sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 10,174 shares — an estimated $91.2K sold.

Landscape Capital Management first reported a position in VIR in Q4 2023 and held it in 2 quarters. The position peaked at $489K in Q4 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Landscape Capital Management reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 10,174 Vir Biotechnology shares in Q2 2026, an estimated $91.2K.
  • Landscape Capital Management first reported a position in Vir Biotechnology in Q4 2023 and held it in 2 quarters.
  • Landscape Capital Management's Vir Biotechnology position peaked at $489K in Q4 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.